Fact CheckerSign in

NCT03150173CompletedPhase 2

Onsite Buprenorphine Treatment at Syringe Exchange Programs

Buprenorphine Treatment at Syringe Exchanges to Reduce Opioid Misuse and HIV Risk

Source: ClinicalTrials.gov · Last updated 11 Dec 2025

Brief summary (registry, in English)

This trial will recruit syringe exchange participants with opioid use disorder in New York City and test whether starting buprenorphine treatment at the syringe exchange program is more effective than referral to a community health center for buprenorphine treatment.

Status (registry)
Completed
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
97 (actual)
First submitted
9 May 2017
Start date
Jan 2019
Primary completion date
Oct 2023
Lead sponsor
Montefiore Medical Center
Diseases
HIV
NCT number
NCT03150173

What you commit to

  • Study type: Interventional · Phase 2
  • Participants enrolled: 97
  • From Jan 2019 to the primary completion date, Oct 2023
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • receiving opioid agonist treatment in the past 30 days (confirmed by New York Prescription Drug Monitoring Program);

Other illness

  • unstable mental illness (e.g., suicidality, psychosis, etc.)
  • severe alcohol use disorder or benzodiazepine use disorder by the Diagnostic and Statistical Manual of Mental disorders, Fifth Edition (DSM-5) criteria
  • hypersensitivity to buprenorphine or naloxone.

Other

  • inability to provide informed consent
  • pregnancy (confirmed via urine testing)

Who the study is looking for

  • age ≥ 18 years
  • opioid use disorder
  • interest in buprenorphine treatment
  • motivation for opioid use disorder treatment
  • willingness to accept community health center referral
  • syringe exchange participant

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Washington Heights CORNER Project
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status
New York Harm Reduction Educators
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status
BOOM!Health Harm Reduction Center
Coordinator of this site? Confirm its status
The BronxUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.